Liu Y, Wang R, Huang R, Rutz B, Ciotkowska A, Tamalunas A
Front Pharmacol. 2023; 14:1105427.
PMID: 37188272
PMC: 10175612.
DOI: 10.3389/fphar.2023.1105427.
Yuki R, Ikeda Y, Yasutake R, Saito Y, Nakayama Y
Sci Rep. 2023; 13(1):2067.
PMID: 36739326
PMC: 9899277.
DOI: 10.1038/s41598-023-29362-w.
Langlois-Lemay L, DAmours D
Front Cell Dev Biol. 2022; 10:930355.
PMID: 35912107
PMC: 9329689.
DOI: 10.3389/fcell.2022.930355.
Zuo Y, He J, Liu S, Xu Y, Liu J, Qiao C
Sci Adv. 2022; 8(14):eabj3887.
PMID: 35394840
PMC: 8993116.
DOI: 10.1126/sciadv.abj3887.
Xiao Y, Dong J
Cancers (Basel). 2021; 13(24).
PMID: 34944834
PMC: 8699626.
DOI: 10.3390/cancers13246214.
Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.
Zhu Z, Wang J, Tan J, Yao Y, He Z, Xie X
J Pathol. 2021; 255(4):374-386.
PMID: 34370292
PMC: 9291001.
DOI: 10.1002/path.5776.
Feedback control of PLK1 by Apolo1 ensures accurate chromosome segregation.
Xu L, Ali M, Duan W, Yuan X, Garba F, Mullen M
Cell Rep. 2021; 36(2):109343.
PMID: 34260926
PMC: 8358895.
DOI: 10.1016/j.celrep.2021.109343.
Mass Spectrometry-Based Discovery of Kinome Substrates.
Sugiyama N
Mass Spectrom (Tokyo). 2020; 9(1):A0082.
PMID: 32547896
PMC: 7242781.
DOI: 10.5702/massspectrometry.A0082.
-GlcNAcylation of myosin phosphatase targeting subunit 1 (MYPT1) dictates timely disjunction of centrosomes.
Liu C, Shi Y, Li J, Liu X, Xiahou Z, Tan Z
J Biol Chem. 2020; 295(21):7341-7349.
PMID: 32295844
PMC: 7247298.
DOI: 10.1074/jbc.RA119.012401.
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
Munoz-Galvan S, Felipe-Abrio B, Verdugo-Sivianes E, Perez M, Jimenez-Garcia M, Suarez-Martinez E
Mol Cancer. 2020; 19(1):7.
PMID: 31926547
PMC: 6954568.
DOI: 10.1186/s12943-020-1130-z.
Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin.
Schipper K, Seinstra D, Drenth A, van der Burg E, Ramovs V, Sonnenberg A
Nat Commun. 2019; 10(1):3800.
PMID: 31444332
PMC: 6707221.
DOI: 10.1038/s41467-019-11716-6.
Dephosphorylation of Plk1 occurs through PP2A-B55/ENSA/Greatwall pathway during mitotic DNA damage recovery.
Kim S, Hyun S, Jang Y
Cell Cycle. 2019; 18(10):1154-1167.
PMID: 31072185
PMC: 6592230.
DOI: 10.1080/15384101.2019.1617003.
Fission Yeast NDR/LATS Kinase Orb6 Regulates Exocytosis via Phosphorylation of the Exocyst Complex.
Tay Y, Leda M, Spanos C, Rappsilber J, Goryachev A, Sawin K
Cell Rep. 2019; 26(6):1654-1667.e7.
PMID: 30726745
PMC: 6367570.
DOI: 10.1016/j.celrep.2019.01.027.
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility.
Angulo-Urarte A, Casado P, Castillo S, Kobialka P, Kotini M, Figueiredo A
Nat Commun. 2018; 9(1):4826.
PMID: 30446640
PMC: 6240100.
DOI: 10.1038/s41467-018-07172-3.
Overexpression of Myosin Phosphatase Target Subunit 1 (MYPT1) Inhibits Tumor Progression and Metastasis of Gastric Cancer.
Wang F, Sun Y
Med Sci Monit. 2018; 24:2508-2517.
PMID: 29687789
PMC: 5937360.
DOI: 10.12659/msm.906852.
Inhibition of Lats1/p-YAP1 pathway mitigates neuronal apoptosis and neurological deficits in a rat model of traumatic brain injury.
Li D, Ji J, Xu Y, Ni H, Rui Q, Liu H
CNS Neurosci Ther. 2018; 24(10):906-916.
PMID: 29488331
PMC: 6489728.
DOI: 10.1111/cns.12833.
Chk1 modulates the interaction between myosin phosphatase targeting protein 1 (MYPT1) and protein phosphatase 1cβ (PP1cβ).
Hu X, Li Z, Ding Y, Geng Q, Xiahou Z, Ru H
Cell Cycle. 2017; 17(4):421-427.
PMID: 29262732
PMC: 5927650.
DOI: 10.1080/15384101.2017.1418235.
Modeling osteosarcoma progression by measuring the connectivity dynamics using an inference of multiple differential modules algorithm.
Liu B, Zhang Z, Dai E, Tian J, Xin J, Xu L
Mol Med Rep. 2017; 16(2):1047-1054.
PMID: 28586048
PMC: 5562023.
DOI: 10.3892/mmr.2017.6703.
Molecular characterization of breast cancer cell lines through multiple omic approaches.
Smith S, Mellor P, Ward A, Kendall S, McDonald M, Vizeacoumar F
Breast Cancer Res. 2017; 19(1):65.
PMID: 28583138
PMC: 5460504.
DOI: 10.1186/s13058-017-0855-0.
Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora.
Bruinsma W, Aprelia M, Garcia-Santisteban I, Kool J, Xu Y, Medema R
Oncogene. 2016; 36(13):1840-1848.
PMID: 27721411
PMC: 5378932.
DOI: 10.1038/onc.2016.347.